Obermueller Eva, Vosseler Silvia, Fusenig Norbert E, Mueller Margareta M
Division of Carcinogenesis and Differentiation, German Cancer Research Center, Heidelberg, Germany.
Cancer Res. 2004 Nov 1;64(21):7801-12. doi: 10.1158/0008-5472.CAN-03-3301.
Tumor growth and progression are critically controlled by alterations in the microenvironment often caused by an aberrant expression of growth factors and receptors. We demonstrated previously that tumor progression in patients and in the experimental HaCaT tumor model for skin squamous cell carcinomas is associated with a constitutive neoexpression of the hematopoietic growth factors granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF), causing an autocrine stimulation of tumor cell proliferation and migration in vitro. To analyze the critical contribution of both factors to tumor progression, G-CSF or GM-CSF was stably transfected in factor-negative benign tumor cells. Forced expression of GM-CSF resulted in invasive growth and enhanced tumor cell proliferation in a three-dimensional culture model in vitro, yet tumor growth in vivo remained only transient. Constitutive expression of G-CSF, however, caused a shift from benign to malignant and strongly angiogenic tumors. Moreover, cells recultured from G-CSF-transfected tumors exhibited enhanced tumor aggressiveness upon reinjection, i.e., earlier onset and faster tumor expansion. Remarkably, this further step in tumor progression was again associated with the constitutive expression of GM-CSF strongly indicating a synergistic action of both factors. Additionally, expression of GM-CSF in the transfected tumors mediated an earlier recruitment of granulocytes and macrophages to the tumor site, and expression of G-CSF induced an enhanced and persistent angiogenesis and increased the number of granulocytes and macrophages in the tumor vicinity. Thus both factors directly stimulate tumor cell growth and, by modulating the tumor stroma, induce a microenvironment that promotes tumor progression.
肿瘤的生长和进展受到微环境改变的严格控制,这种改变通常由生长因子和受体的异常表达引起。我们之前证明,在皮肤鳞状细胞癌的患者以及实验性HaCaT肿瘤模型中,肿瘤进展与造血生长因子粒细胞集落刺激因子(G-CSF)和粒细胞-巨噬细胞集落刺激因子(GM-CSF)的组成性新表达有关,这在体外导致肿瘤细胞增殖和迁移的自分泌刺激。为了分析这两种因子对肿瘤进展的关键作用,将G-CSF或GM-CSF稳定转染到因子阴性的良性肿瘤细胞中。在体外三维培养模型中,GM-CSF的强制表达导致侵袭性生长并增强肿瘤细胞增殖,但体内肿瘤生长仅为短暂性。然而,G-CSF的组成性表达导致从良性肿瘤向恶性且具有强烈血管生成能力的肿瘤转变。此外,从转染了G-CSF的肿瘤中重新培养的细胞在再次注射后表现出增强的肿瘤侵袭性,即更早发病和更快的肿瘤扩展。值得注意的是,肿瘤进展的这进一步步骤再次与GM-CSF的组成性表达相关,强烈表明这两种因子具有协同作用。此外,转染肿瘤中GM-CSF的表达介导粒细胞和巨噬细胞更早募集到肿瘤部位,而G-CSF的表达诱导增强且持续的血管生成,并增加肿瘤附近粒细胞和巨噬细胞的数量。因此,这两种因子都直接刺激肿瘤细胞生长,并通过调节肿瘤基质诱导促进肿瘤进展的微环境。